These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21592585)

  • 21. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis.
    Durán-Ferrer M; Léon L; Nielsen K; Caporale V; Mendoza J; Osuna A; Perales A; Smith P; De-Frutos C; Gómez-Martín B; Lucas A; Chico R; Delgado OD; Escabias JC; Arrogante L; Díaz-Parra R; Garrido F
    Vet Microbiol; 2004 Jun; 100(3-4):219-31. PubMed ID: 15145500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M.
    Motaharinia Y; Rezaee MA; Rashidi A; Jalili A; Rezaie MJ; Shapouri R; Hossieni W; Rahmani MR
    J Microbiol Immunol Infect; 2013 Aug; 46(4):253-8. PubMed ID: 22727892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of a novel camel single-domain antibody specific for the type III mutant EGFR.
    Omidfar K; Rasaee MJ; Modjtahedi H; Forouzandeh M; Taghikhani M; Golmakani N
    Tumour Biol; 2004; 25(5-6):296-305. PubMed ID: 15627895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of naïve camelids VHH repertoire in phage display-based library.
    Sabir JS; Atef A; El-Domyati FM; Edris S; Hajrah N; Alzohairy AM; Bahieldin A
    C R Biol; 2014 Apr; 337(4):244-9. PubMed ID: 24702893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.
    Estein SM; Cheves PC; Fiorentino MA; Cassataro J; Paolicchi FA; Bowden RA
    Vet Microbiol; 2004 Sep; 102(3-4):203-13. PubMed ID: 15327795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of rabbit polyclonal antibody against camel recombinant nanobodies.
    Khalaf HE; Al-Bouqaee H; Hwijeh M; Abbady AQ
    Open Life Sci; 2022; 17(1):659-675. PubMed ID: 35800073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bactrian camel nanobody-based immunoassay for specific and sensitive detection of Cry1Fa toxin.
    Wang P; Li G; Yan J; Hu Y; Zhang C; Liu X; Wan Y
    Toxicon; 2014 Dec; 92():186-92. PubMed ID: 25448390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of High-Quality Camel Immune Antibody Libraries.
    Romão E; Poignavent V; Vincke C; Ritzenthaler C; Muyldermans S; Monsion B
    Methods Mol Biol; 2018; 1701():169-187. PubMed ID: 29116505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein.
    Al-Mariri A
    Vaccine; 2010 Feb; 28(7):1766-70. PubMed ID: 20036752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved performance of Brucella melitensis native hapten over Brucella abortus OPS tracer on goat antibody detection by the fluorescence polarization assay.
    Ramírez-Pfeiffer C; Díaz-Aparicio E; Rodríguez-Padilla C; Morales-Loredo A; Alvarez-Ojeda G; Gomez-Flores R
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):223-9. PubMed ID: 18359093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of homologous antigen in the serological diagnosis of brucellosis caused by Brucella melitensis.
    Tittarelli M; Giovannini A; Conte A; Di Ventura M; Nannini D; Caporale V
    J Vet Med B Infect Dis Vet Public Health; 2005 Mar; 52(2):75-81. PubMed ID: 15752266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect enzyme-linked immunosorbent assay for detection of Brucella melitensis-specific antibodies in goat milk.
    Funk ND; Tabatabai LB; Elzer PH; Hagius SD; Martin BM; Hoffman LJ
    J Clin Microbiol; 2005 Feb; 43(2):721-5. PubMed ID: 15695670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
    Yang X; Walters N; Robison A; Trunkle T; Pascual DW
    Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.